Related Experiment Video

Updated: Jun 15, 2026

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

The role of endothelial cells and their progenitors in intimal hyperplasia

S D Patel1, M Waltham, A Wadoodi

  • 1King's College London BHF Centre Cardiovascular Division, NIHR Biomedical Research Centre at Guy's & St Thomas' NHS Foundation Trust, London, UK.

Therapeutic Advances in Cardiovascular Disease
|March 5, 2010
PubMed

Insights

Endothelial progenitor cells show therapeutic potential for preventing intimal hyperplasia and restenosis after cardiovascular interventions. Further research into vascular progenitor cell biology is needed for successful clinical trials.

Area of Science:

  • Cardiovascular research
  • Regenerative medicine
  • Vascular biology

Background:

  • Intimal hyperplasia (IH) leading to restenosis is a primary limitation in cardiovascular interventions.
  • Vascular progenitor cells, especially endothelial progenitor cells (EPCs), are of significant interest for therapeutic applications in preventing IH.
  • A functional endothelium plays a crucial role in attenuating IH, and EPCs are vital for maintaining endothelial function.

Purpose of the Study:

  • To review the mechanisms of intimal hyperplasia.
  • To highlight the role of endothelial progenitor cells in maintaining endothelial function and preventing IH.
  • To discuss the therapeutic potential and limitations of EPCs in clinical settings.

Main Methods:

  • Review of existing literature on intimal hyperplasia mechanisms.
  • Analysis of the role of endothelial progenitor cells and other stem cell sources in endothelial repair.
  • Examination of clinical trial outcomes using EPCs for restenosis prevention.

Main Results:

  • Reduced EPC number and function, along with impaired endothelial function, increase the risk of IH.
  • EPCs have demonstrated varied success in clinical trials aimed at reducing restenosis.
  • Other potential endothelial cell sources include monocytes, mesenchymal stem cells, and tissue-resident stem cells.

Conclusions:

  • Endothelial progenitor cells hold significant therapeutic promise for preventing intimal hyperplasia.
  • A deeper understanding of vascular progenitor cell biology is essential before widespread clinical application.
  • Further research is required to optimize the use of progenitor cells in cardiovascular interventions.

More Related Videos

Using a Cell-Tracer Injection to Investigate the Origin of Neointima-Forming Cells in a Rat Saccular Side Wall Model05:41

Using a Cell-Tracer Injection to Investigate the Origin of Neointima-Forming Cells in a Rat Saccular Side Wall Model

Published on: March 16, 2022

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure07:02

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure

Published on: May 15, 2020

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
Structure of Blood Vessels01:15

Structure of Blood Vessels

Blood is circulated throughout the human body through a network of blood vessels called the circulatory system. This system includes arteries that transport blood from the heart to various body parts. These arterial pathways divide into smaller vessels until they reach the arterioles, which further split into capillaries. It is within these minuscule capillaries that the exchange of nutrients and waste products takes place. After this exchange, the blood is collected by venules, which fuse to...